Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 17, 2002
Gene therapy for pyruvate dehydrogenase E1alpha deficiency using recombinant adeno-associated virus 2 (rAAV2) vectors
Renius Owen, Ronald J Mandel, Chandramohan V Ammini, et al.
Human Gene Therapy
|
January 18, 2006
Systemic correction of a fatty acid oxidation defect by intramuscular injection of a recombinant adeno-associated virus vector
Thomas J Conlon, Glenn Walter, Renius Owen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 9, 2005
Efficient hepatic delivery and expression from a recombinant adeno-associated virus 8 pseudotyped alpha1-antitrypsin vector
Thomas J Conlon, Travis Cossette, Kirsten Erger, et al.
Journal of Inherited Metabolic Disease
|
May 27, 2018
Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia
Young Mok Lee, Thomas J Conlon, Andrew Specht, et al.
Human Gene Therapy
|
November 13, 2012
Regression of schwannomas induced by adeno-associated virus-mediated delivery of caspase-1
Shilpa Prabhakar, Mehran Taherian, Davide Gianni, et al.
Circulation Research
|
July 29, 2006
Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo
Christina A Pacak, Cathryn S Mah, Bijoy D Thattaliyath, et al.
Human Gene Therapy Methods
|
June 15, 2012
Retrograde gene delivery to hypoglossal motoneurons using adeno-associated virus serotype 9
Mai K ElMallah, Darin J Falk, Michael A Lane, et al.
Human Gene Therapy. Clinical Development
|
September 12, 2013
Preclinical toxicology and biodistribution studies of recombinant adeno-associated virus 1 human acid α-glucosidase
Thomas J Conlon, Kirsten Erger, Stacy Porvasnik, et al.
Human Gene Therapy. Clinical Development
|
September 22, 2015
Evaluation of Readministration of a Recombinant Adeno-Associated Virus Vector Expressing Acid Alpha-Glucosidase in Pompe Disease: Preclinical to Clinical Planning
Manuela Corti, Brian Cleaver, Nathalie Clément, et al.
Human Gene Therapy
|
June 17, 2015
Stability and Safety of an AAV Vector for Treating RPGR-ORF15 X-Linked Retinitis Pigmentosa
Wen-Tao Deng, Frank M Dyka, Astra Dinculescu, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 17, 2002
Gene therapy for pyruvate dehydrogenase E1alpha deficiency using recombinant adeno-associated virus 2 (rAAV2) vectors
Renius Owen, Ronald J Mandel, Chandramohan V Ammini, et al.
Human Gene Therapy
|
January 18, 2006
Systemic correction of a fatty acid oxidation defect by intramuscular injection of a recombinant adeno-associated virus vector
Thomas J Conlon, Glenn Walter, Renius Owen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 9, 2005
Efficient hepatic delivery and expression from a recombinant adeno-associated virus 8 pseudotyped alpha1-antitrypsin vector
Thomas J Conlon, Travis Cossette, Kirsten Erger, et al.
Journal of Inherited Metabolic Disease
|
May 27, 2018
Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia
Young Mok Lee, Thomas J Conlon, Andrew Specht, et al.
Human Gene Therapy
|
November 13, 2012
Regression of schwannomas induced by adeno-associated virus-mediated delivery of caspase-1
Shilpa Prabhakar, Mehran Taherian, Davide Gianni, et al.
Circulation Research
|
July 29, 2006
Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo
Christina A Pacak, Cathryn S Mah, Bijoy D Thattaliyath, et al.
Human Gene Therapy Methods
|
June 15, 2012
Retrograde gene delivery to hypoglossal motoneurons using adeno-associated virus serotype 9
Mai K ElMallah, Darin J Falk, Michael A Lane, et al.
Human Gene Therapy. Clinical Development
|
September 12, 2013
Preclinical toxicology and biodistribution studies of recombinant adeno-associated virus 1 human acid α-glucosidase
Thomas J Conlon, Kirsten Erger, Stacy Porvasnik, et al.
Human Gene Therapy. Clinical Development
|
September 22, 2015
Evaluation of Readministration of a Recombinant Adeno-Associated Virus Vector Expressing Acid Alpha-Glucosidase in Pompe Disease: Preclinical to Clinical Planning
Manuela Corti, Brian Cleaver, Nathalie Clément, et al.
Human Gene Therapy
|
June 17, 2015
Stability and Safety of an AAV Vector for Treating RPGR-ORF15 X-Linked Retinitis Pigmentosa
Wen-Tao Deng, Frank M Dyka, Astra Dinculescu, et al.
Page
of 5